Weber P, Martínek K
Vnitr Lek. 1989 Aug;35(8):802-8.
The authors applied the oral glucose tolerance test (oGTT) in 21 patients with bioptically confirmed cirrhosis without clinical or laboratory signs of manifest diabetes. At the same time they used the oGTT in 11 healthy controls. During the test they assessed the venous glycaemia, insulin and C-peptide and from these values they calculated relative indexes. In cirrhotic patients they recorded during the oGTT higher blood sugar levels, and higher insulin and C-peptide in the majority of time intervals [blood sugar during the 90th minute p greater than 0.01 and 120th minute p greater than 0.05; immunoreactive insulin (IRI) in the 90th minute p greater than 0.05 and in the 120th minute p greater than 0.01), i.e. typical hyperinsulinaemia with a retarded secretory maximum during the 90th minute. The calculation of the molar ratio C-peptide: IRI is considered useful by the authors. In cirrhotic patients it was markedly reduced on fasting, during the 60th, 90th and 120th minute (p greater than 0.01). In the discussion the authors analyze the problem of enhanced insular secretion, impaired hepatic extraction and insulin resistance in relation to disorders of glucose tolerance in cirrhosis.
作者对21例经活检证实为肝硬化且无明显糖尿病临床或实验室体征的患者进行了口服葡萄糖耐量试验(oGTT)。同时,他们对11名健康对照者也进行了oGTT。在试验过程中,他们评估了静脉血糖、胰岛素和C肽,并根据这些值计算了相关指标。在肝硬化患者中,他们在oGTT期间记录到较高的血糖水平,并且在大多数时间间隔内胰岛素和C肽水平也较高[第90分钟时血糖p>0.01,第120分钟时血糖p>0.05;第90分钟时免疫反应性胰岛素(IRI)p>0.05,第120分钟时IRI p>0.01],即典型的高胰岛素血症,且在第90分钟时分泌高峰延迟。作者认为计算C肽与IRI的摩尔比是有用的。在肝硬化患者中,空腹时以及第60、90和120分钟时该比值均显著降低(p>0.01)。在讨论中,作者分析了与肝硬化患者葡萄糖耐量异常相关的胰岛分泌增强、肝脏摄取受损和胰岛素抵抗问题。